Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression.

Scandinavian journal of infectious diseases - 1 Jan 2005

Kristiansen Thomas B, Pedersen Anders G, Eugen-Olsen Jesper, Katzenstein Terese L, Lundgren Jens D

Abstract excerpt

Our objective was to investigate whether steadily increasing resistance levels are inevitable in the course of a failing but unchanged Highly Active Antiretroviral Therapy (HAART) regimen. Patients having an unchanged HAART regimen and a good CD4 response (100 cells/microl above nadir) despite consistent HIV-RNA levels above 200 copies/ml were included in the study. The study period spanned at least 12 months and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genes, Viral

Share to HIV Infections

Share to RNA, Viral

Share to Treatment Failure

Source

Identifiers

PMID: 16308226
DOI: 10.1080/00365540500333491

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression.PMID 16308226Read ↗

Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.Semantic proximity Read ↗

Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.Semantic proximity Read ↗

Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure.Semantic proximity Read ↗

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.Semantic proximity Read ↗

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.Semantic proximity Read ↗

Development of drug resistance mutations in patients on highly active antiretroviral therapy: does competitive advantage drive evolution.Semantic proximity Read ↗

HIV-resistance evolution requires new strategies. Mutation risk higher if HIV RNA increases.Semantic proximity Read ↗

Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV LoadsSemantic proximity Read ↗

Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.Semantic proximity Read ↗

Evolutionary pathways of transmitted drug-resistant HIV-1Semantic proximity Read ↗

Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virusSemantic proximity Read ↗

Recent trends in HIV-1 drug resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.